Rasi Bhadramani
Hedge funds increased their overweight positioning in health care (NYSEARCA:XLV) despite a 7% decline in the sector during the second quarter, according to Goldman Sachs’s Hedge Fund Trend Monitor.
The concentration was mostly seen in biotech and pharmaceuticals.
Also, vs. the Russell